Hospital Universitario Fundacion Jimenez Diaz

At Hospital Universitario Fundacion Jimenez Diaz in Madrid, a major share of research focuses on neoplasms and blood cancers, with studies spanning non-small cell lung cancer, breast cancer, ovarian cancer, lymphoma, and multiple myeloma. These trials are largely designed to test new cancer treatments, combine therapies in smarter ways, and improve outcomes for patients with advanced or treatment-resistant disease.

• Solid tumors including lung, breast, ovarian, colorectal, pancreatic, hepatobiliary, and gastrointestinal cancers
• Lymphomas and other hematologic malignancies such as diffuse large B-cell lymphoma, mantle cell lymphoma, and multiple myeloma
• Research aimed at evaluating immunotherapy, targeted treatment strategies, and treatment effectiveness in advanced cancer

The oncology portfolio is broad and highly active, reflecting the site’s strong role in studies of both common and rare cancers, with a clear emphasis on finding better options for people whose disease has progressed after standard care.

Cardiovascular studies at this site address conditions such as heart failure, acute myocardial infarction, and inherited risk for dilated cardiomyopathy, while renal research includes chronic kidney disease and focal segmental glomerulosclerosis. The main purpose is to improve prevention, protect organ function, and evaluate whether new approaches can reduce complications after major cardiac events or surgery.

• Heart failure, acute decompensated heart failure, and post-infarction recovery
• Genetic cardiomyopathy and strategies to prevent early disease progression
• Kidney disease research focused on preserving renal function and reducing surgery-related injury

These studies combine disease prevention and treatment optimization, showing a strong interest in earlier intervention and better long-term outcomes for patients with cardiovascular and kidney disorders.

Research in nervous system diseases includes trials for epilepsy, focal onset seizures, chronic migraine, and glioblastoma, along with studies exploring sleep-related symptoms such as insomnia. The goal is to assess new therapies that may better control symptoms, reduce seizure burden, and improve daily functioning.

• Epilepsy and focal seizures in adults and younger patients
• Insomnia and sleep disturbance linked with other health conditions
• Brain tumor research, especially glioblastoma, focused on improving treatment response

This area reflects a practical clinical focus on conditions that can strongly affect quality of life, with trials seeking safer and more effective ways to manage persistent neurological symptoms.

The site also conducts research in digestive system diseases and immune-related conditions, including Crohn's disease, complex perianal fistulas, hepatocellular carcinoma, cholangiocarcinoma, and other gastrointestinal cancers. These studies aim to improve treatment options, support healing in inflammatory bowel disease, and evaluate new approaches for hard-to-treat liver and gastrointestinal malignancies.

• Crohn's disease and associated fistulizing complications
• Hepatobiliary cancers such as hepatocellular carcinoma and cholangiocarcinoma
• Gastrointestinal cancers including gastroesophageal and colon malignancies

These trials highlight a mix of regenerative, surgical, and drug-based research, all aimed at improving control of chronic inflammation and difficult digestive cancers.

Additional research at Hospital Universitario Fundacion Jimenez Diaz covers eye diseases, virus diseases, and immune system diseases, including geographic atrophy, uveitic macular edema, HIV-1 infection, RSV-associated disease, and monkeypox. The main aim is to improve diagnosis, preserve vision, and test better preventive or treatment options for infectious and immune-driven conditions.

• Retinal and inflammatory eye disease, especially geographic atrophy and uveitic macular edema
• HIV-1 treatment and treatment-switch studies
• Viral infections and vaccine-related research for emerging and respiratory pathogens

This portfolio shows the site’s wide clinical reach, extending beyond oncology and cardiology into vision care, infectious disease, and immune-mediated disorders where better long-term control is needed.